Investing in ASX 200 blue chip shares is arguably one of the most reliable ways to build long-term wealth.
These companies are typically industry leaders with strong competitive advantages, stable earnings, and a history of delivering solid returns to shareholders.
With that in mind, let's take a look at two ASX 200 blue chip shares that could be buys with $2,000 according to analysts at Goldman Sachs. Here's what the broker is saying about these shares:
ResMed Inc. (ASX: RMD)
Goldman Sachs has named ResMed as an ASX 200 blue chip share to buy.
It is a leading sleep disorder treatment company with a world class portfolio of devices and software to treat sleep apnoea and other conditions.
The broker believes that ResMed's shares are undervalued at current levels and deserve to trade on higher multiples. Especially considering its very positive growth outlook. It recently said:
RMD is the world's leading CPAP manufacturer of devices and masks in the treatment of OSA. The company has expanded to providing software services to out of hospital healthcare providers including Durable Equipment Manufacturers (DMEs), nursing homes and home health and hospice agencies.
Our Buy recommendation on RMD is premised on (1) Ongoing robust new patient growth for CPAP therapy despite the market entry of GLP-1 drugs to treat OSA, (2) Further RMD market share gains, building on its #1 global market position, (3) Expansion of the OSA market in regions outside of the US. We believe the stock's current trading multiple is unjustified based on its growth outlook.
Goldman has a buy rating and $49.00 price target on its shares. This implies potential upside of almost 27% for investors from current levels.
Woolworths Group Ltd (ASX: WOW)
Analysts at Goldman Sachs also think that Woolworths could be among the best ASX 200 blue chip shares to buy right now.
Particularly given the supermarket giant's very attractive valuation and positive growth outlook as the omni-channel leader in Australian retail. The broker explains:
With channel shift into online continuing, our recent e-Comm deep dive still suggests that WOW has the best omni-channel and digital retail capabilities amongst Australian retailers.
The stock is trading at FY26e P/E of ~20x, approximately -1std below its historical average, we expect recovery in market share and cost discipline and scaling of retail media to drive recovery in AU Food EBIT margin, with trough earnings in NZ/W Living also support earnings recovery from 2H25 onwards.
Goldman Sachs has a buy rating and $36.10 price target on Woolworths' shares. Based on its current share price of $29.70, this implies potential upside of almost 22% for investors.
